Skip to content

Clinical trials

Completed Phase 1 Fragile X Syndrome trials

Search ClinicalTrials.gov registrations by keyword, then narrow by condition, phase, status, country and start year.

Filters: Condition: Fragile X Syndrome Phase: Phase 1 Status: Completed Clear all

11 trials match Source: ClinicalTrials.gov registrations

Trials started per year

By phase, 2000 to 2026.

Trials started per year
CategoryTrials
20051
20092
20121
20131
20151
20162
20171
20181
20231

Status

Trials by registry status. Select a bar to filter.

Trials by status
CategoryTrials
Completed11

Top lead sponsors

A sponsor with a page on Pharma Observatory links to it.

Top lead sponsors
CategoryTrials
Children's Hospital Medical Center, Cincinnati3
Connecta Therapeutics, S.L.1
Healx AI1
Institute for Neurodegenerative Disorders1
Novartis Pharmaceuticals1
Queen's University, Belfast1
Seaside Therapeutics, Inc.1
Stanford University1
University Hospital, Tours1

Top conditions

MeSH conditions the trials were registered with, not their broader categories. A condition with a page on Pharma Observatory links to it.

Top conditions
CategoryTrials
Fragile X Syndrome11
Autistic Disorder2
Intellectual Disability2
Alzheimer Disease1
Angelman Syndrome1
Autism Spectrum Disorder1
Central Nervous System Diseases1
Cognitive Dysfunction1
Congenital Abnormalities1
Down Syndrome1

Trials

Showing 1 to 11 of 11. Each trial links to its page on Pharma Observatory.

Recently changed trials

Changes observed in the last 7 days, newest first, site-count changes left out. Source: ClinicalTrials.gov.

No changes to these trials in the last 7 days.

Go deeper on Pharma Observatory

Pharma Observatory connects clinical trials, sponsors, sites and investigators in one searchable platform.